Apeloa Pharmaceutical Co.,Ltd (000739.SZ)
- Previous Close
13.92 - Open
13.99 - Bid 13.94 x --
- Ask 13.95 x --
- Day's Range
13.83 - 14.02 - 52 Week Range
12.70 - 18.96 - Volume
7,905,875 - Avg. Volume
12,314,557 - Market Cap (intraday)
16.312B - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
15.67 - EPS (TTM)
0.89 - Earnings Date --
- Forward Dividend & Yield 0.32 (2.28%)
- Ex-Dividend Date May 23, 2024
- 1y Target Est
19.42
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People's Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.
www.apeloa.com7,060
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 000739.SZ
View MorePerformance Overview: 000739.SZ
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 000739.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 000739.SZ
View MoreValuation Measures
Market Cap
--
Enterprise Value
13.66B
Trailing P/E
15.66
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.40
Price/Book (mrq)
2.33
Enterprise Value/Revenue
1.18
Enterprise Value/EBITDA
11.14
Financial Highlights
Profitability and Income Statement
Profit Margin
8.97%
Return on Assets (ttm)
4.53%
Return on Equity (ttm)
15.37%
Revenue (ttm)
11.55B
Net Income Avi to Common (ttm)
1.04B
Diluted EPS (ttm)
0.89
Balance Sheet and Cash Flow
Total Cash (mrq)
3.47B
Total Debt/Equity (mrq)
10.90%
Levered Free Cash Flow (ttm)
310.45M